Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Learn smart ways to save + get daily chances to win gift cards ...

South Carolina hasn’t had the season it wanted to have, at least up to this point. But Week 9 brings the potential for new hope and a new beginning, with the Gamecocks hosting No. 4 Alabama on ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

(Alliance News) - GSK PLC said Thursday its drug Blenrep has been approved by the US Food & Drug Administration for the treatment of adults with relapsed or refractory multiple myeloma, the third most ...

Belantamab mafodotin, a BCMA-targeting ADC, is approved for relapsed/refractory multiple myeloma after two prior therapies, showing significant PFS and OS benefits in the DREAMM-7 trial. The drug ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer. Adding the drug enzalutamide to standard hormone therapy reduced the risk of ...

Nomad has launched its latest Apple Watch accessory, the Stratos Band. It combines lightweight and durable titanium with FKM rubber for a breathable, comfortable, and durable watch band, unlike ...

The Cincinnati Bengals shared their NFL Week 8 uniform combo for their game Oct. 26 against the 0-7 New York Jets, declaring on social media that they're "getting in the Halloween spirit" with a black ...

Exelixis Inc. (NASDAQ:EXEL) stock is trading lower on Monday after the company shared detailed results from the STELLAR-303 Phase 3 trial. In June, the company said the study met one of its dual ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...